0
Eyenovia, Inc. Banner Image

Eyenovia, Inc.

  • Ticker EYEN
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Eyenovia, Inc. Logo Image
  • 11-50 Employees
  • Based in New York City, New York
Eyenovia, Inc. (NASDAQ: EYEN) is a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose array print (MAP™) therapeutics. Eyenovia’s pipeline is currently focused on the late-stage development of microdosed medications for presbyopia, myopia progression and mydriasis.
REPORT RATINGS
4.8 / 5.0 (185)

Eyenovia, Inc. reports have an aggregate usefulness score of 4.8 based on 185 reviews.

Eyenovia, Inc.

Most Recent Annual Report

Eyenovia, Inc.
MOST RECENT 2022 Annual Report and Form 10K

Older/Archived Annual Reports

Eyenovia, Inc. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!